EKSO BIONICS HLDGS INC's ticker is and the CUSIP is 282644301. A total of 24 filers reported holding EKSO BIONICS HLDGS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,201 | -53.2% | 98,455 | -8.7% | 0.00% | – |
| Q2 2023 | $154,199 | -13.3% | 107,832 | 0.0% | 0.00% | – |
| Q1 2023 | $177,922 | +138901.6% | 107,832 | 0.0% | 0.00% | – |
| Q4 2022 | $128 | -99.9% | 107,832 | -0.3% | 0.00% | – |
| Q3 2022 | $168,000 | -5.6% | 108,122 | 0.0% | 0.00% | – |
| Q2 2022 | $178,000 | -42.9% | 108,122 | 0.0% | 0.00% | – |
| Q1 2022 | $312,000 | +9.1% | 108,122 | 0.0% | 0.00% | – |
| Q4 2021 | $286,000 | -42.7% | 108,122 | 0.0% | 0.00% | – |
| Q3 2021 | $499,000 | -16.0% | 108,122 | 0.0% | 0.00% | – |
| Q2 2021 | $594,000 | +47.8% | 108,122 | +65.8% | 0.00% | – |
| Q1 2021 | $402,000 | +111.6% | 65,206 | +109.3% | 0.00% | – |
| Q4 2020 | $190,000 | +52.0% | 31,149 | +17.8% | 0.00% | – |
| Q3 2020 | $125,000 | -43.7% | 26,438 | 0.0% | 0.00% | – |
| Q2 2020 | $222,000 | +200.0% | 26,438 | +0.0% | 0.00% | – |
| Q1 2020 | $74,000 | – | 26,435 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ESSEX INVESTMENT MANAGEMENT CO LLC | 220,513 | $161,636 | 0.03% |
| Strategic Wealth Investment Group, LLC | 42,665 | $31,274 | 0.01% |
| Legato Capital Management LLC | 12,038 | $8,824 | 0.00% |
| Allworth Financial LP | 64 | $47 | 0.00% |
| VANGUARD GROUP INC | 436,925 | $320,266 | 0.00% |
| ALBION FINANCIAL GROUP /UT | 67 | $50 | 0.00% |
| UBS Group AG | 148 | $108 | 0.00% |
| Compagnie Lombard Odier SCmA | 25,000 | $18,325 | 0.00% |
| Tradewinds Capital Management, LLC | 260 | $191 | 0.00% |
| Eukles Asset Management | 13 | $10 | 0.00% |